Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Weekly insulin injections can control type 1 and type 2 diabetes just as well as daily shots, according to two new studies.

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators ... forced ...

Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

The retrospective study involved reviewing the medical charts of 100 adults with T1D ... All of the participants were taking insulin for their diabetes. Insulin pumps were used by 75% of those ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

Application error: a client-side exception has occurred (see the browser console for more information).